{
  "retracted": false,
  "timestamp": 1533081600000,
  "updates": [
    {
      "timestamp": 1586836304258,
      "identifier": {
        "doi": "10.1016/j.breast.2018.04.007"
      },
      "type": "erratum"
    }
  ],
  "identifier": {
    "doi": "10.1016/j.breast.2018.04.007"
  },
  "publisher": "Elsevier BV",
  "title": "Erratum to “First-line ribociclib plus letrozole for postmenopausal women with HR+, HER2- ABC: MONALEESA-2 safety results” [Breast 36 (Suppl. 1) (November 2017) S44–S45]"
}
